The Banded Mini Gastric Bypass Trial: A Prospective Randomized Controlled Trial

Launched by MARC VAN DET · Jul 20, 2022

Keywords

ClinConnect Summary

The Banded Mini Gastric Bypass Trial is studying a new approach to weight loss surgery called the mini gastric bypass (MGB) combined with a device called the MiniMizer Ring. This trial aims to find out if patients who have this surgery will lose more weight over five years compared to traditional methods. The focus will be on how much total body weight patients lose, as well as improvements in health conditions related to obesity like diabetes and high blood pressure, and how the surgery affects their quality of life.

To participate in this study, you need to be an adult with a body mass index (BMI) of 35 or higher and have related health issues, or a BMI over 40. The trial is currently looking for volunteers and will involve several check-ups before and after the surgery to monitor progress. While the surgery may help with weight loss and related health problems, there are also potential risks, such as complications from the MiniMizer Ring. It’s important for anyone considering this study to understand both the benefits and risks involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients meet IFSO criteria for Bariatric Surgery
• • Age 18 and above
• Exclusion Criteria:
• • Previous Bariatric surgery
• • Inability to read and understand written information
• • Any genetic condition that can hamper the acceptance of medical advice
• • chronic bowel disease
• • Severe kidney of liver disease
• • Pregnancy at the start or during the research period
• • Patients with pre-existing therapy refractory GERD
• • Patients with an allergy to silicone